AMY2B | Amylase, alpha 2B (pancreatic) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PPY | Pancreatic polypeptide | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enriched |
GPHA2 | Glycoprotein hormone alpha 2 | Predicted secreted proteins
| | | | | Tissue enriched |
RP11-664D7.4 | HCG1787533; Uncharacterized protein | | | | | | Group enriched |
TRPV6 | Transient receptor potential cation channel, subfamily V, member 6 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
ERP27 | Endoplasmic reticulum protein 27 | Predicted secreted proteins
| | | | | Tissue enriched |
FOXA3 | Forkhead box A3 | Transcription factors
| | | | | Group enriched |
LHFPL5 | Lipoma HMGIC fusion partner-like 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
NEUROD1 | Neuronal differentiation 1 | Disease related genes Transcription factors
| | | | | Group enriched |
PM20D1 | Peptidase M20 domain containing 1 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
REG3G | Regenerating islet-derived 3 gamma | Predicted secreted proteins
| | | | | Group enriched |
SPINK1 | Serine peptidase inhibitor, Kazal type 1 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CELA1 | Chymotrypsin-like elastase family, member 1 | Enzymes
| | | | | Group enriched |
DNASE1 | Deoxyribonuclease I | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Group enriched |
GRPR | Gastrin-releasing peptide receptor | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
KCNK16 | Potassium channel, subfamily K, member 16 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
LEFTY1 | Left-right determination factor 1 | Predicted secreted proteins
| | | | | Group enriched |
NGB | Neuroglobin | | | | | | Group enriched |
REG1A | Regenerating islet-derived 1 alpha | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SARDH | Sarcosine dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
SLC17A4 | Solute carrier family 17, member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC22A31 | Solute carrier family 22, member 31 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC30A8 | Solute carrier family 30 (zinc transporter), member 8 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
TMEM52 | Transmembrane protein 52 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ADARB2 | Adenosine deaminase, RNA-specific, B2 (non-functional) | | | | | | Group enriched |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
COCH | Cochlin | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
FBXW12 | F-box and WD repeat domain containing 12 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
GNMT | Glycine N-methyltransferase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
GUCA1C | Guanylate cyclase activator 1C | | | | | | Group enriched |
PAX6 | Paired box 6 | Disease related genes Transcription factors
| | | | | Group enriched |
PKHD1 | Polycystic kidney and hepatic disease 1 (autosomal recessive) | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
PTPRN | Protein tyrosine phosphatase, receptor type, N | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
SLC30A2 | Solute carrier family 30 (zinc transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
C1orf127 | Chromosome 1 open reading frame 127 | Predicted secreted proteins
| | | | | Group enriched |
GAMT | Guanidinoacetate N-methyltransferase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
GCG | Glucagon | Predicted secreted proteins
| | | | | Tissue enriched |
SST | Somatostatin | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
ABCC8 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AC007461.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AC131097.4 | Protein LOC285095 | | | | | | Tissue enhanced |
ALDH1L2 | Aldehyde dehydrogenase 1 family, member L2 | Enzymes
| | | | | Tissue enhanced |
ARHGDIG | Rho GDP dissociation inhibitor (GDI) gamma | | | | | | Tissue enhanced |
ARSE | Arylsulfatase E (chondrodysplasia punctata 1) | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BCAT1 | Branched chain amino-acid transaminase 1, cytosolic | Enzymes
| | | | | Tissue enhanced |
BRSK2 | BR serine/threonine kinase 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
C2CD4B | C2 calcium-dependent domain containing 4B | | | | | | Tissue enhanced |
C8orf12 | Chromosome 8 open reading frame 12 | | | | | | Tissue enhanced |
C8orf47 | Chromosome 8 open reading frame 47 | | | | | | Tissue enhanced |
CABP7 | Calcium binding protein 7 | Predicted membrane proteins
| | | | | Tissue enhanced |